Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation - Moghetti, P; Castello, R; Negri, C (J Clin Endocrinol Metab, 2000)
et al.